Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Matsuoka

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Hematology|June 15, 2007
Complete remission induced by gemtuzumab ozogamicin in a Jehovah's Witness patient with acute myelogenous leukemiaShinya Fujisawa, Kensuke Naito, Toshihiko Matsuoka, et al.
International Journal of Hematology|May 26, 2005
CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphomaShinya Fujisawa, Fumihiko Tanioka, Toshihiko Matsuoka, et al.
International Journal of Hematology|June 8, 2006
CD7/CD19 double-positive T-cell acute lymphoblastic leukemiaShinya Fujisawa, Fumihiko Tanioka, Toshihiko Matsuoka, et al.
International Journal of Environmental Research and Public Health|October 21, 2016
High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd ImmunityToshihiko Matsuoka, Tomoki Sato, Tomoyuki Akita, et al.
Hiroshima Journal of Medical Sciences|March 5, 2015
Cost-effectiveness of the introduction of low-dose CT screening in Japanese smokers aged 55 to 74 years oldHiroki Tabata, Tomoyuki Akita, Akiko Matsuura, et al.
Plos One|June 24, 2020
The Tokyo subway sarin attack has long-term effects on survivors: A 10-year study started 5 years after the terrorist incidentAya Sugiyama, Toshihiko Matsuoka, Kazuaki Sakamune, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2015
Estimated numbers of patients with liver disease related to hepatitis B or C virus infection based on the database reconstructed from medical claims from 2008 to 2010 in JapanMasayuki Ohisa, Yuki Kimura, Junko Matsuo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Hematology|June 15, 2007
Complete remission induced by gemtuzumab ozogamicin in a Jehovah's Witness patient with acute myelogenous leukemiaShinya Fujisawa, Kensuke Naito, Toshihiko Matsuoka, et al.
International Journal of Hematology|May 26, 2005
CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphomaShinya Fujisawa, Fumihiko Tanioka, Toshihiko Matsuoka, et al.
International Journal of Hematology|June 8, 2006
CD7/CD19 double-positive T-cell acute lymphoblastic leukemiaShinya Fujisawa, Fumihiko Tanioka, Toshihiko Matsuoka, et al.
International Journal of Environmental Research and Public Health|October 21, 2016
High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd ImmunityToshihiko Matsuoka, Tomoki Sato, Tomoyuki Akita, et al.
Hiroshima Journal of Medical Sciences|March 5, 2015
Cost-effectiveness of the introduction of low-dose CT screening in Japanese smokers aged 55 to 74 years oldHiroki Tabata, Tomoyuki Akita, Akiko Matsuura, et al.
Plos One|June 24, 2020
The Tokyo subway sarin attack has long-term effects on survivors: A 10-year study started 5 years after the terrorist incidentAya Sugiyama, Toshihiko Matsuoka, Kazuaki Sakamune, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2015
Estimated numbers of patients with liver disease related to hepatitis B or C virus infection based on the database reconstructed from medical claims from 2008 to 2010 in JapanMasayuki Ohisa, Yuki Kimura, Junko Matsuo, et al.
Pageof 1